A study of pulmonary function in end-stage renal disease patients on hemodialysis
a cross-sectional study
Keywords:
Kidney diseases, Respiratory function tests, Renal dialysisAbstract
BACKGROUND: The aim here was to study acute effects of hemodialysis among end-stage renal disease (ESRD) patients. DESIGN AND SETTING: Prospective study in tertiary-level care center. METHODS: Fifty ESRD patients undergoing hemodialysis were studied. Spirometric pulmonary function tests were performed before and after four-hour hemodialysis sessions. RESULTS: The patients’ average age was 45.8 ± 10.0 years; 64% were males and 64% had normal body mass index. Anemia (94%) and hypoalbuminemia (72%) were common. Diabetes mellitus (68%), hypertension (34%) and coronary artery disease (18%) were major comorbidities. Forty-five patients (90%) had been on hemodialysis for six months to three years. The patients’ pre-dialysis mean forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) were below normal: 45.8 ± 24.9% and 43.5 ± 25.9% of predicted, respectively. After hemodialysis, these increased significantly, to 51.1 ± 23.4% and 49.3 ± 25.5% of predicted, respectively (P < 0.01). The increase in mean FEV1/FVC, from 97.8 ± 20.8% to 99.3 ± 20.1% of predicted, was not significant (P > 0.05). The pre-dialysis mean forced expiratory flow 25-75% was 50.1 ± 31% and increased significantly, to 56.3 ± 31.6% of predicted (P < 0.05). The mean peak expiratory flow was below normal (43.8 ± 30.7%) and increased significantly, to 49.1 ± 29.9% of predicted (P < 0.05). Males and females showed similar directions of change after hemodialysis. CONCLUSIONS: Pulmonary function abnormalities are common among ESRD patients. Comparison of pre and post-hemodialysis parameters showed significant improvements, but normal predicted values were still not achieved.
Downloads
References
US Renal Data System, Annual data report: atlas of end-stage renal disease in the United States. Bethesda: National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases; 2002. Available from: https://www.usrds.org/atlas02.aspx Accessed in 2017 (Sep 11).
Brenner BM, Mackenzie HS. Disturbances of renal function. In: Fauci AS, Braunwald E, Isselbacher KJ, et al., editors. Harrison's Principles of Internal Medicine. 17th ed. New York: McGraw-Hill Companies; 2008. p. 1761-71.
Pierson JD. Respiratory considerations in the patient with renal failure. Respir Care. 2006;51(4):413-22.
Navari K, Farshidi H, Pour-Reza-Gholi F, et al. Spirometry parameters in patients undergoing hemodialysis with bicarbonate and acetate dialysates. Iran J Kidney Dis. 2008;2(3):149-53.
Parmar MS. Chronic renal disease. BMJ. 2002;325(7355):85-90.
Karacan O, Tutal E, Colak T, et al. Pulmonary function in renal transplant recipients and end-stage renal disease patients undergoing maintenance dialysis. Transplant Proc. 2006;38(2):396-400.
Lang SM, Becker A, Fischer R, Huber RM, Schiffl H. Acute effects of hemodialysis on lung function in patients with end-stage renal disease. Wien Klin Wochenschr. 2006;118(3-4):108-13.
Rahgoshai R, Rahgoshai R, Khosraviani A, Nasiri AA, Solouki M. Acute effects of hemodialysis on pulmonary function in patients with end-stage renal disease. Iran J Kidney Dis. 2010;4(3):214-7.
Senatore M, Buemi M, Di Somma A, Sapio C, Gallo GC. [Respiratory function abnormalities in uremic patients]. G ltal Nefrol. 2004;21(1):29-33.
Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med. 1977;296(14):769-74.
Zidulka A, Despas PJ, Milic-Emili J, Anthonisen NR. Pulmonary function with acute loss of excess lung water by hemodialysis in patients with chronic uremia. Am J Med. 1973;55(2):134-41.
Silva VG, Amaral C, Monterio MB, Nascimento DM, Boschetti JR. Efeitos do treinamento muscular inspiratório nos pacientes em hemodiálise [Effects of inspiratory muscle training in hemodialysis patients]. J Bras Nefrol. 2011;33(1):62-8.
Lim VS, Ikizler TA, Raj DS, Flanigan MJ. Does hemodialysis increase protein breakdown? Dissociation between whole-body amino acid turnover and regional muscle kinetics. J Am Soc Nephrol. 2005;16(4):862-8.
Adams GR, Vaziri ND. Skeletal muscle dysfunction in chronic renal failure: effect of exercise. Am J Physiol Renal Physiol. 2006;290(4):F753-61.
Mahmoud BL, Abdulkader A, El-Sharkawy MM, Khalil HH. Assessment of pulmonary functions in chronic renal failure patients with different haemodialysis regimens. J Egypt Soc Parasitol. 2004;34(3):1025-40.
Nascimento MM, Quershi RA, Stenvinkel P, et al. Malnutrition and inflammation are associated with impaired pulmonary function in patients with chronic kidney disease. Nephrol Dial Transplant. 2004;19(7):1823-8.
Bark H, Heimer D, Chaimovitz C, Mostoslovski M. Effect of chronic renal failure on respiratory muscle strength. Respiration. 1988;54(3):153-61.
Prezant DJ. Effect of uremia and its treatment on pulmonary function. Lung. 1990;168(1):1-14.
Yoon SH, Choi NW, Yun SR. Pulmonary dysfunction is possibly a marker of malnutrition and inflammation but not mortality in patients with end-stage renal disease. Nephron Clin Pract. 2009;111(1):c1-6.
Rajkovaca Z, Kovacevic P, Jakovljevic B, Eric Z. Detection of pulmonary calcification in haemodialised patients by whole-body scintigraphy and the impact of the calcification to parameters of spirometry. Bosn J Basic Med Sci. 2010;10(4):303-6.
Davenport A, Williams AJ. Fall in peak expiratory flow during haemodialysis in patients with chronic renal failure. Thorax. 1988;43(9):693-6.
